Skip to search formSkip to main contentSkip to account menu

GALNT14 gene

Known as: UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE 14, polypeptide N-acetylgalactosaminyltransferase 14, polypeptide GalNAc transferase 14 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
  • Wey-Ran LinC. Yeh
  • International Journal of Molecular Sciences
  • 2020
  • Corpus ID: 211522345
Members of the polypeptide N-acetylgalactosaminyltransferase (GALNT) family function as the initiating enzymes that catalyze… 
Highly Cited
2016
Highly Cited
2016
GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment
Some polypeptide N-acetyl-galactosaminyltransferases (GALNTs) are associated with cancer, but their function in organ-specific… 
2016
2016
MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
2016
2016
GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
AIM Transcatheter arterial chemoembolization is currently the standard treatment in hepatocellular carcinoma patients with… 
Highly Cited
2015
Highly Cited
2015
GALNT14 mediates tumor invasion and migration in breast cancer cell MCF‐7
Aberrant glycosylation is a hallmark of most human cancers and affects many cellular properties, including cell proliferation… 
2015
2015
Identification of GALNT14 as a novel neuroblastoma predisposition gene
Although several genes have been associated to neuroblastoma (NB) predisposition and aggressiveness, further genes are likely… 
2014
2014
GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.
In addition to targeted agents, chemotherapy is currently considered to be a treatment option for patients with advanced… 
2013
2013
The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
A high expression of O-glycosylated proteins is one of the prominent characteristics of ovarian carcinoma cells associated with… 
2011
2011
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC.
AIM Despite the availability of targeted anticancer agents, combination chemotherapy remains an option for patients with far… 
2010
2010
Development of Immunohistochemistry Assays to Assess GALNT14 and FUT3/6 in Clinical Trials of Dulanermin and Drozitumab
Purpose: In vitro sensitivity to the proapoptotic receptor agonists dulanermin (rhApo2L/TRAIL) and drozitumab (DR5-agonist… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)